APA

Weber J. S., Zarour H., Redman B., Trefzer U., O'Day S., van den Eertwegh A. J. M., Marshall E. & Wagner S. (20091001). Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma. : Cancer.

Chicago

Weber Jeffrey S, Zarour Hassan, Redman Bruce, Trefzer Uwe, O'Day Steven, van den Eertwegh Alfons J M, Marshall Ernest and Wagner Stefan. 20091001. Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma. : Cancer.

Harvard

Weber J. S., Zarour H., Redman B., Trefzer U., O'Day S., van den Eertwegh A. J. M., Marshall E. and Wagner S. (20091001). Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma. : Cancer.

MLA

Weber Jeffrey S, Zarour Hassan, Redman Bruce, Trefzer Uwe, O'Day Steven, van den Eertwegh Alfons J M, Marshall Ernest and Wagner Stefan. Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma. : Cancer. 20091001.